We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MXCT market cap is 292.92M. The company's latest EPS is USD -0.3664 and P/E is -10.02.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 21.62M | 26.17M | 33.89M | 44.26M | 41.29M |
Operating Income | -12.42M | -11.06M | -18.19M | -27.36M | -48.3M |
Net Income | -12.9M | -11.82M | -19.08M | -23.57M | -37.92M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 29.99M | 51.78M | 284.12M | 286.65M | 268.27M |
Total Liabilities | 16.38M | 18.56M | 21.22M | 32.69M | 36.11M |
Total Equity | 13.6M | 33.23M | 262.9M | 253.97M | 232.17M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -8.8M | -8.78M | -10.68M | -14.78M | -21.69M |
Investing | 455k | -16.58M | -195.01M | -24.82M | 54.98M |
Financing | 12.31M | 28.9M | 234.72M | 2.89M | 2.14M |
Market Cap | 292.92M |
Price to Earnings Ratio | -10.02 |
Price to Sales Ratio | 9.2 |
Price to Cash Ratio | 8.17 |
Price to Book Ratio | 1.64 |
Dividend Yield | - |
Shares Outstanding | 103.5M |
Average Volume (1 week) | 66.13k |
Average Volume (1 Month) | 19.32k |
52 Week Change | 28.64% |
52 Week High | 420.00 |
52 Week Low | 214.00 |
Spread (Intraday) | 6 (2.1%) |
Company Name | Maxcyte Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.maxcyte.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions